BIO · NYSE, NYSE · CIK 0000012208

BIO-RAD LABORATORIES, INC.

BIO-RAD LABORATORIES, INC.’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 27, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $2.6B and net income of $759.9M, according to its XBRL data on EDGAR. Its EDGAR record lists 24 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$2.6B
Net income, FY2025
$759.9M
Form 4 filings on record, past 12 months
24

Company overview

Legal name (as filed)
BIO-RAD LABORATORIES, INC.
Tickers
BIO, BIO-B
SEC Central Index Key (CIK)
0000012208
Industry (SIC)
Laboratory Analytical Instruments (code 3826)
Business address
HERCULES, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#928 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BIO-RAD LABORATORIES, INC.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$2.9BFY2021$2.8BFY2022$2.7BFY2023$2.6BFY2024$2.6BFY2025
Net income
$4.3BFY2021-$3.6BFY2022-$637.3MFY2023-$1.8BFY2024$759.9MFY2025
BIO annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$2.9B$2.8B$2.7B$2.6B$2.6B
Net income$4.3B-$3.6B-$637.3M-$1.8B$759.9M
Diluted EPS$140.83-$121.79-$21.82-$65.36$27.85
Total assets$17.8B$13.5B$12.3B$9.4B$10.6B
Cash and equivalents$470.8M$434.2M$403.8M$488.1M$529.8M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BIO latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 13, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 4, 20268-KResults of operations; Exit or disposal costs; Regulation FD disclosure· period Jul 31, 2026Document · Index
Mar 25, 2026DEF 14ADEFINITIVE PROXY STATEMENT· period Apr 21, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about BIO-RAD LABORATORIES, INC., by form type:

4 ×238-K ×5144 ×410-Q ×2SD ×1S-8 ×1SCHEDULE 13G/A ×1ARS ×1DEF 14A ×110-K ×1
BIO recent filings
FiledFormWhat it isOriginal
Oct 27, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 24, 2026Document · Index
Oct 22, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 20, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 9, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026Document · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 4, 20268-KResults of operations; Exit or disposal costs; Regulation FD disclosure· period Jul 31, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 25, 2026Document · Index
May 28, 2026144Notice of proposed sale of securitiesDocument · Index
May 13, 20264Statement of changes in beneficial ownership (insider trade)· period May 11, 2026Document · Index
May 13, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 11, 2026144Notice of proposed sale of securitiesDocument · Index
Apr 30, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Apr 30, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 30, 20268-KResults of operations; Regulation FD disclosure· period Apr 30, 2026Document · Index
Apr 28, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 24, 2026Document · Index
Apr 28, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 24, 2026Document · Index
Apr 24, 20268-KDirector or officer change; Shareholder vote results· period Apr 21, 2026Document · Index
Apr 23, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 21, 2026Document · Index
Apr 23, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 21, 2026Document · Index
Apr 23, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 21, 2026Document · Index
Apr 23, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 21, 2026Document · Index
Mar 26, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 25, 2026ARSARS· period Dec 31, 2025Document · Index
Mar 25, 2026DEF 14ADEFINITIVE PROXY STATEMENT· period Apr 21, 2026Document · Index
Feb 19, 20268-KRegulation FD disclosure· period Feb 19, 2026Document · Index
Feb 13, 202610-KAnnual report· period Dec 31, 2025Document · Index
Feb 12, 20268-KResults of operations; Regulation FD disclosure· period Feb 12, 2026Document · Index
Dec 2, 2025144Notice of proposed sale of securitiesDocument · Index
Nov 18, 2025144Notice of proposed sale of securitiesDocument · Index
Nov 10, 20254Statement of changes in beneficial ownership (insider trade)· period Nov 6, 2025Document · Index

Insider filing activity

24 Form 4 filings appear in BIO-RAD LABORATORIES, INC.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Laboratory Analytical Instruments

All 12 companies in Laboratory Analytical Instruments· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000012208 and XBRL company facts. BIO-RAD LABORATORIES, INC. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.